Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation

Journal of the American College of Cardiology

Volumn 65, Issue 9, 2015, Pages 867-875

  Stavrakis, Stavros ^a   Humphrey, Mary Beth ^b   Scherlag, Benjamin J ^a   Hu, Yanqing ^b   Jackman, Warren M ^a   Nakagawa, Hiroshi ^a   Lockwood, Deborah ^a   Lazzara, Ralph ^a   Po, Sunny S ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

atrial fibrillation; autonomic nervous system; inflammation; neuromodulation

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DISEASE DURATION; FEMALE; FEMORAL VEIN; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; IMMUNOASSAY; LOW LEVEL TRAGUS ELECTRICAL STIMULATION; MALE; NEUROMODULATION; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRANSCUTANEOUS NERVE STIMULATION; VAGUS NERVE STIMULATION; ATRIAL FIBRILLATION; BLOOD; ELECTROCARDIOGRAPHY; MIDDLE AGED; PROCEDURES;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE STIMULATION;

EID: 84924706130     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.12.026     Document Type: Article

References (37)

1. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
3. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906
4. F. Ouyang, R. Tilz, and J. Chun Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up Circulation 122 2010 2368 2377
5. R. Weerasooriya, P. Khairy, and J. Litalien Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57 2011 160 166
6. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
7. E. Ben-Menachem Vagus-nerve stimulation for the treatment of epilepsy Lancet Neurol 1 2002 477 482
8. G.M. De Ferrari, H.J. Crijns, M. Borggrefe for the CardioFit Multicenter Trial Investigators Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure Eur Heart J 32 2011 847 855
9. S. Li, B.J. Scherlag, and L. Yu Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation Circ Arrhythm Electrophysiol 2 2009 645 651
10. Y. Sha, B.J. Scherlag, and L. Yu Low-level right vagal stimulation: anticholinergic and antiadrenergic effects J Cardiovasc Electrophysiol 22 2011 1147 1153
11. X. Sheng, B.J. Scherlag, and L. Yu Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation J Am Coll Cardiol 57 2011 563 571
12. L. Yu, B.J. Scherlag, and S. Li Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia J Cardiovasc Electrophysiol 22 2011 455 463
13. L. Yu, B.J. Scherlag, and Y. Sha Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle Heart Rhythm 9 2012 804 809
14. M.J. Shen, T. Shinohara, and H.W. Park Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines Circulation 123 2011 2204 2212
15. L. Yu, B.J. Scherlag, and S. Li Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation Heart Rhythm 10 2013 428 435
16. M. Haissaguerre, P. Sanders, and M. Hocini Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome Circulation 109 2004 3007 3013
17. C. Evereklioglu, H. Er, Y. Turkoz, and M. Cekmen Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease Mediators Inflamm 11 2002 87 93
18. J.A. Armour, D.A. Murphy, B.X. Yuan, S. Macdonald, and D.A. Hopkins Gross and microscopic anatomy of the human intrinsic cardiac nervous system Anat Rec 247 1997 289 298
19. D.H. Pauza, V. Skripka, N. Pauziene, and R. Stropus Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart Anat Rec 259 2000 353 382
20. D.G. Katritsis, E. Pokushalov, and A. Romanov Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial J Am Coll Cardiol 62 2013 2318 2325
21. E. Patterson, R. Lazzara, and B. Szabo Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins J Am Coll Cardiol 47 2006 1196 1206
22. B. Richter, M. Gwechenberger, P. Filzmoser, M. Marx, P. Lercher, and H.D. Gossinger Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor? Eur Heart J 27 2006 2553 2559
23. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
24. K. Friedrichs, A. Klinke, and S. Baldus Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 2011 556 563
25. J. Li, J. Solus, and Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
26. H.S. Lim, S.R. Willoughby, and C. Schultz Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm J Am Coll Cardiol 61 2013 852 860
27. A.T. Masi, A.A. Rehman, K.B. Elmore, and J.C. Aldag Serum acute phase protein and inflammatory cytokine network correlations: comparison of a pre-rheumatoid arthritis and non-rheumatoid arthritis community cohort J Innate Immun 5 2013 100 113
28. P.M. Ridker, R.J. Glynn, and C.H. Hennekens C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction Circulation 97 1998 2007 2011
29. P.M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage, and E. Braunwald Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2000 2149 2153
30. J.M. Huston, and K.J. Tracey The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy J Intern Med 269 2011 45 53
31. L.V. Borovikova, S. Ivanova, and M. Zhang Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 405 2000 458 462
32. H. Wang, M. Yu, and M. Ochani Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 2003 384 388
33. Y. Zhang, Z.B. Popovic, and S. Bibevski Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model Circ Heart Fail 2 2009 692 699
34. J.M. Huston, M. Gallowitsch-Puerta, and M. Ochani Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis Crit Care Med 35 2007 2762 2768
35. P.J. Schwartz, G.M. De Ferrari, and A. Sanzo Long term vagal stimulation in patients with advanced heart failure: first experience in man Eur J Heart Fail 10 2008 884 891
36. H. Stefan, G. Kreiselmeyer, and F. Kerling Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial Epilepsia 53 2012 e115 e118
37. K. Shinlapawittayatorn, K. Chinda, and S. Palee Low-amplitude, left vagus nerve stimulation significantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury Heart Rhythm 10 2013 1700 1707